{"id":"https://openalex.org/W4400546455","doi":"https://doi.org/10.1097/01.hjh.0001027104.84084.c5","title":"81. The Intersection of Tuberculosis Treatment and Blood Pressure Control: Insights from Primary Healthcare - A Case Report","display_name":"81. The Intersection of Tuberculosis Treatment and Blood Pressure Control: Insights from Primary Healthcare - A Case Report","publication_year":2024,"publication_date":"2024-05-01","ids":{"openalex":"https://openalex.org/W4400546455","doi":"https://doi.org/10.1097/01.hjh.0001027104.84084.c5"},"language":"en","primary_location":{"id":"doi:10.1097/01.hjh.0001027104.84084.c5","doi":"https://doi.org/10.1097/01.hjh.0001027104.84084.c5","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.hjh.0001027104.84084.c5","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103313894","display_name":"Muhammad Nurhazim Nugroho","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Muhammad Nurhazim Nugroho","raw_affiliation_strings":["General Practitioner, Puskesmas Depok 1 Sleman, Special Region of Yogyakarta, Indonesia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General Practitioner, Puskesmas Depok 1 Sleman, Special Region of Yogyakarta, Indonesia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5116230020","display_name":"Rifqi Rizkani Eri","orcid":"https://orcid.org/0009-0006-3428-8833","observed_orcids":["https://orcid.org/0009-0006-3428-8833"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rifqi Rizkani Eri","raw_affiliation_strings":["General Practitioner, Abdi Waluyo Hospital, Jakarta, Indonesia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General Practitioner, Abdi Waluyo Hospital, Jakarta, Indonesia","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"Suppl 2","first_page":"e21","last_page":"e21"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.062300000339746475,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tuberculosis","display_name":"tuberculosis","score":0.8100000023841858},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.9449999928474426},{"id":"https://openalex.org/keywords/antituberculosis-drugs","display_name":"antitubercular agents","score":0.8140000104904175},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9169999957084656},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.7889999747276306},{"id":"https://openalex.org/keywords/amlodipine","display_name":"amlodipine","score":0.9819999933242798},{"id":"https://openalex.org/keywords/captopril","display_name":"captopril","score":0.7160000205039978},{"id":"https://openalex.org/keywords/hydrochlorothiazide","display_name":"hydrochlorothiazide","score":0.9959999918937683},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.6769999861717224},{"id":"https://openalex.org/keywords/cyp3a4-induction","display_name":"CYP3A4 induction","score":0.9179999828338623},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.7279999852180481},{"id":"https://openalex.org/keywords/primary-care","display_name":"primary care","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9802969694137573},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.6345704793930054},{"id":"https://openalex.org/C64543145","wikidata":"https://www.wikidata.org/wiki/Q162942","display_name":"Intersection (aeronautics)","level":2,"score":0.6258741021156311},{"id":"https://openalex.org/C3018038924","wikidata":"https://www.wikidata.org/wiki/Q1189184","display_name":"Tuberculosis control","level":3,"score":0.6178801655769348},{"id":"https://openalex.org/C163432668","wikidata":"https://www.wikidata.org/wiki/Q623543","display_name":"Primary health care","level":3,"score":0.5511958003044128},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5085235834121704},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3778654634952545},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3304026126861572},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2965744733810425},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12176981568336487},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.11470931768417358},{"id":"https://openalex.org/C22212356","wikidata":"https://www.wikidata.org/wiki/Q775325","display_name":"Transport engineering","level":1,"score":0.053635209798812866},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.hjh.0001027104.84084.c5","doi":"https://doi.org/10.1097/01.hjh.0001027104.84084.c5","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.hjh.0001027104.84084.c5","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7221210150","https://openalex.org/W4389195908","https://openalex.org/W3086239789","https://openalex.org/W7208808072","https://openalex.org/W2012114118","https://openalex.org/W2026498621","https://openalex.org/W2359151064","https://openalex.org/W4378840278","https://openalex.org/W2401095127","https://openalex.org/W3088315346"],"abstract_inverted_index":{"Introduction:":[0],"Tuberculosis":[1],"and":[2,14,106,149,185,191,206,244],"hypertension":[3,33,51,231,253],"often":[4],"coexist,":[5],"necessitating":[6],"concurrent":[7],"management.":[8,34],"However,":[9],"the":[10,27,66,127,156,198,227,240],"interaction":[11],"between":[12,62],"antituberculosis":[13,30,77,130,171,234,259],"antihypertensive":[15,91,182],"medications,":[16],"particularly":[17,173],"calcium":[18],"channel":[19],"blockers":[20],"(CCBs),":[21],"remains":[22],"underexplored.":[23],"This":[24,224],"case":[25,225],"highlights":[26,226],"impact":[28,180],"of":[29,48,89,96,129,145,189,201,214,229,242],"therapy":[31,92],"on":[32,181],"Case":[35],"Presentation:":[36],"A":[37,86],"53-year-old":[38],"female":[39],"diagnosed":[40],"with":[41,53],"pulmonary":[42],"tuberculosis":[43,124],"also":[44,209],"had":[45],"a":[46,93,142],"history":[47],"chronic":[49],"essential":[50],"managed":[52],"amlodipine":[54,97,146],"10":[55,98,147],"mg":[56,99,103,109,148,152],"daily,":[57,100,105],"maintaining":[58,118],"blood":[59],"pressure":[60],"(BP)":[61],"120-141/74-83":[63],"mmHg":[64,122,160],"for":[65,161,211,256],"last":[67],"4":[68],"months":[69,163],"at":[70,120,158],"our":[71],"primary":[72],"healthcare":[73],"center.":[74],"Upon":[75],"initiating":[76],"treatment,":[78,131,172,235],"her":[79,90,113,132],"BP":[80,114,133,157,169],"gradually":[81,134],"rose":[82],"to":[83,136,141,218,250],"146-168/78-90":[84],"mmHg.":[85,138],"gradual":[87],"augmentation":[88],"three-drug":[94],"regimen":[95,144],"captopril":[101,150],"25":[102,108],"twice":[104,153],"hydrochlorothiazide":[107],"daily":[110,154],"effectively":[111],"controlled":[112],"within":[115],"1.5":[116],"months,":[117],"stability":[119],"128-145/77-82":[121],"throughout":[123],"therapy.":[125,260],"Following":[126],"completion":[128],"declined":[135],"110-133/70-78":[137],"Sequential":[139],"de-escalation":[140],"two-drug":[143],"12.5":[151],"sustained":[155],"114-136/72-81":[159],"several":[162],"thereafter.":[164],"Discussion:":[165],"The":[166],"rise":[167],"in":[168],"during":[170,233],"rifampicin,":[174],"prompts":[175],"an":[176],"exploration":[177],"into":[178],"its":[179],"drug":[183],"metabolism":[184,200],"efficacy.":[186,207],"Rifampicin\u2019s":[187],"induction":[188,220],"hepatic":[190],"intestinal":[192],"cytochrome":[193],"P450":[194],"(CYP)":[195],"3A4":[196],"enhances":[197],"first-pass":[199],"CCBs,":[202],"diminishing":[203],"their":[204],"bioavailability":[205],"There\u2019s":[208],"potential":[210],"diminished":[212],"effectiveness":[213],"beta-blockers":[215],"(BBs)":[216],"due":[217],"CYP2D6":[219],"by":[221],"rifampicin.":[222],"Conclusion:":[223],"importance":[228],"managing":[230],"carefully":[232],"as":[236],"rifampicin":[237],"may":[238],"reduce":[239],"efficacy":[241],"CCBs":[243],"BBs.":[245],"Further":[246],"studies":[247],"are":[248],"needed":[249],"develop":[251],"optimal":[252],"treatment":[254],"strategies":[255],"patients":[257],"undergoing":[258]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2024-07-12T00:00:00"}